Breakthrough transplant offers hope for blood disorder cure without harsh chemo
NCT ID NCT06743477
Summary
This study is testing a new type of stem cell transplant called 'hypertransplantation' that aims to cure severe thalassemia, a serious inherited blood disorder. The new approach skips the usual harsh chemotherapy and radiation before transplant, which could eliminate many dangerous side effects and complications. Researchers are enrolling children aged 7-12 with severe thalassemia to see if this method is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yunnan First People's Hospital
RECRUITINGKunming, Yunnan, 650000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.